Bangladesh
Tuberculosis profile
| High TB burden | High MDR-TB burden |
Population  2012 155 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 70 (29–130) 45 (19–84)
Mortality (HIV+TB only) 0.092 (0.082–0.1) 0.06 (0.05–0.07)
Prevalence  (includes HIV+TB) 670 (340–1 100) 434 (218–721)
Incidence  (includes HIV+TB) 350 (290–410) 225 (185–268)
Incidence (HIV+TB only) 0.24 (0.2–0.29) 0.16 (0.13–0.19)
Case detection, all forms (%) 49 (41–59)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 106 790 (66) Relapse 3 065 (38)
Smear-negative 24 451 (15) Treatment after failure 807 (10)
Smear-unknown / not done 0 (0) Treatment after default 257 (3)
Extrapulmonary 30 549 (19) Other 3 872 (48)
Other 0 (0)      
Total new 161 790   Total retreatment 8 001  
           
Other (history unknown) 3 828        
Total new and relapse 164 855   Total cases notified 173 619  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.9 1.9 0.9
Age < 15 966 1 109 2 767
Laboratories 2012
Smear (per 100 000 population) 0.7
Culture (per 5 million population) <0.1
Drug susceptibility testing (per 5 million population) <0.1
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 92   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 89  
Retreatment 82  
TB/HIV 2012 Number (%)
TB patients with known HIV status 2 086 (1)
HIV-positive TB patients 63 (3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 63 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 63 (100)
HIV-positive people screened for TB 429  
HIV-positive people provided with IPT 0  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.4 (0.7–2.5) 29 (24–34)
MDR-TB cases among notified pulmonary
TB cases
1 900 (920–3 300) 2 300 (1 900–2 700)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 41 (<1%) 557 (7%) 622
Laboratory-confirmed MDR-TB cases 10 503 513
Patients started on MDR-TB treatment     513
Financing TB control 2013
National TB programme budget (US$ millions) 43
% Funded domestically <1%
% Funded internationally 19%
% Unfunded 80%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data